Neuroone Medical Technologies is trading 6.15% higher at $1.38, with no confirmed company-specific catalyst identified.
- It closed at $1.30 on September 21, 2026.
- No new company-specific announcement, filing, or analyst action was identified for September 22.
- The September 17 Southern California distribution agreement remains the latest reported news, while broader markets are mixed and Nasdaq is modestly higher; available coverage does not directly connect either factor to today’s rebound.